Risk of brain tumors in children and susceptibility to organophosphorus insecticides: The potential role of paraoxonase (PON1)

Environmental Health Perspectives

Volumn 113, Issue 7, 2005, Pages 909-913

  Nielsen, Susan Searles ^a,b   Mueller, Beth A ^a,b   De Roos, Anneclaire J ^a,b   Viernes, Hannah Malia A ^b   Farin, Federico M ^b   Checkoway, Harvey ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Brain tumor; Children; Chlorpyrifos; Diazinon; Dried blood spots; Guthrie cards; Paraoxonase; Pesticides; PON1; Xenobiotic metabolism

Indexed keywords

ARGININE; ARYLDIALKYLPHOSPHATASE; CYSTEINE; DNA; GLUTAMINE; ORGANOPHOSPHATE INSECTICIDE; THREONINE;

ALLELE; ARTICLE; BRAIN TUMOR; CANCER RISK; CHILD; CHILDHOOD CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOTHER; NEUROECTODERM TUMOR; NEWBORN; NEWBORN SCREENING; PEST CONTROL; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN STRUCTURE; STATISTICAL SIGNIFICANCE; UNITED STATES;

ARYLDIALKYLPHOSPHATASE; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHILD; CHLORPYRIFOS; DIAZINON; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSECTICIDES; NEUROECTODERMAL TUMORS, PRIMITIVE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 22144452878     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7680     Document Type: Article

References (36)

1. American Society of Human Genetics. 1996. ASHG report. Statement on informed consent for genetic research. Am J Hum Genet 59:471-474.
2. Andrew Clayton C, Pellizzari ED, Whitmore RW, Quackenboss JJ, Adgate J, Sefton K. 2003. Distributions, associations, and partial aggregate exposure of pesticides and polynuclear aromatic hydrocarbons in the Minnesota Children's Pesticide Exposure Study (MNCPES). J Expo Anal Environ Epidemiol 13:100-111.
3. Antognelli C, Mearini L, Talesa VN, Giannantoni A, Mearini E. 2OD4. Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer. Prostate 63:240-251. doi:10/1002/pros.20184 [Online 10 November 2004].
4. Au WW, Sierra-Torres CH, Cajas-Salazar N, Shipp BK, Legator MS. 1999. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ Health Perspect 107:501-505.
5. Breslow NE, Day NE, eds. 1980. Statistical Methods in Cancer Research: Vol I. The Analysis of Case-Control Studies. Lyon, France:IARC Press.
6. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. 2001. Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 68:1428-1436.
7. Brophy VH, Jarvik GP, Furlong CE. 2002. PON1 Polymorphisms. In: Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects (Costa LG, Furlong CE, eds). Boston:Kluwer Academic Publishers, 53-77.
8. Bunin GR, Buckley JD, Boesel CP, Rorke LB, Meadows AT. 1994. Risk factors for astrocytic glioma and primitive neuroectodermal tumor of the brain in young children: a report from the Children's Cancer Group. Cancer Epidemiol Biomarkers Prev 3:197-204.
9. Chen J, Kumar M, Chan W, Berkowitz G, Wetmur JG. 2003. Increased influence of genetic variation on PON1 activity in neonates. Environ Health Perspect 111:1403-1409.
10. Cole TB, Jampsa RL, Walter BJ, Arndt TL, Richter RJ, Shih DM, et al. 2003. Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13:357-364.
11. Cordier S, Mandereau L, Preston-Martin S, Little J, Lubin F, Mueller B, et al. 2001. Parental occupations and childhood brain tumors: results of an international case-control study. Cancer Causes Control 12:865-874.
12. Costa LG, Furlong CE. 2002. Perspectives in PON1 Research. In: Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects (Costa L, Furlong CE, eds). Boston:Kluwer Academic Publishers, 197-210.
13. Costa LG, Li WF, Richter RJ, Shih DM, Lusis AJ, Furlong CE. 2002. PON1 and Organophosphate Toxicity. In: Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects (Costa L, Furlong CE, eds). Boston:Kluwer Academic Publishers, 165-183.
14. Costa LG, Vitalone A, Cole TB, Furlong CE. 2005. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541-550.
15. Davis JR, Brownson RC, Garcia R, Bentz BJ, Turner A. 1993. Family pesticide use and childhood brain cancer. Arch Environ Contam Toxicol 24:87-92.
16. Deakin S, Leviev I, Brulhart-Meynet MC, James RW. 2003. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position -107, implicating the Sp1 transcription factor. Biochem J 372:643-649.
17. Donaldson D, Kiely T, Grube A. 2002. 1998/1999 Pesticide Sales and Usage Report. Washington, DC:U.S. Environmental Protection Agency.
18. Efird JT, Holly EA, Preston-Martin S, Mueller BA, Lubin F, Filippini G, et al. 2003. Farm-related exposures and childhood brain tumours in seven countries: results from the SEARCH International Brain Tumour Study. Paediatr Perinat Epidemiol 17:201-211.
19. Garcia SJ, Seidler FJ, Crumpton TL, Slotkin TA. 2001. Does the developmental neurotoxicity of chlorpyrifos involve glial targets? Macromolecule synthesis, adenylyl cyclase signaling, nuclear transcription factors, and formation of reactive oxygen in C6 glioma cells. Brain Res 891:54-68.
20. Garcia SJ, Seidler FJ, Qiao D, Slotkin TA. 2002. Chlorpyrifos targets developing glia: effects on glial fibrillary acidic protein. Brain Res Dev Brain Res 133:151-161.
21. Gurney J, Smith M, Bunin G. 1999. CNS and miscellaneous intracranial and intraspinal neoplasms. In: Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995 (Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, et al., eds). NIH Pub. No. 99-4649. Bethesda, MD:National Institutes of Health, 51-63.
22. Gurney JG, Mueller BA, Davis S, Schwartz SM, Stevens RG, Kopecky KJ. 1996. Childhood brain tumor occurrence in relation to residential power line configurations, electric heating sources, and electric appliance use. Am J Epidemiol 143:120-128.
23. Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, et al. 2004. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11:412-419.
24. Holly EA, Bracci PM, Mueller BA, Preston-Martin S. 1998. Farm and animal exposures and pediatric brain tumors: results from the United States West Coast Childhood Brain Tumor Study. Cancer Epidemiol Biomarkers Prev 7:797-802.
25. Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, et al. 2002. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 22:1329-1333.
26. Johnson DE, Seidler FJ, Slotkin TA. 1998. Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chloropyrifos. Brain Res Bull 45:143-147.
27. Kerridge I, Lincz L, Scorgie F, Hickey D, Granter N, Spencer A. 2002. Association between xenobiotic gene polymerphisms and non-Hodgkin's lymphoma risk. Br J Haematol 118:477-481.
28. Kristensen P, Andersen A, Irgens LM, Bye AS, Sundheim L. 1996. Cancer in offspring of parents engaged in agricultural activities in Norway: incidence and risk factors in the farm environment. Int J Cancer 65:39-50.
29. Leviev I, James RW. 2000. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol 20:516-521.
30. Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, et al. 2000. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10:767-779.
31. Lincz LF, Kerridge I, Scorgie FE, Bailey M, Enno A, Spencer A. 20134. Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Haematologica 89:628-629.
32. Marchesani M, Hakkarainen A, Tuomainen TP, Kaikkonen J, Pukkala E, Uimari P, et al. 2003. New paraoxonase 1 polymorphism l102V and the risk of prostate cancer in Finnish men. J Natl Cancer Inst 95:812-818.
33. Pogoda JM, Preston-Martin S. 1997. Household pesticides and risk of pediatric brain tumors. Environ Health Perspect 105:1214-1220.
34. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
35. U.S. Department of Agriculture. 2004. Pesticide Data Program: Annual Summary Calendar Year 2002. Washington, DC:U.S. Department of Agriculture, Agricultural Marketing Service.
36. WHO. 1976. International Classification of Diseases for Oncology. 1st ed. Geneva:World Health Organization.